Somogyi AA - Search Results

1

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.

Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, Dunnenberger HM, Leeder JS, Callaghan JT, Samer CF, Klein TE, Haidar CE, Van Driest SL, Ruano G, Sangkuhl K, Cavallari LH, Müller DJ, Prows CA, Nagy M, Somogyi AA, Skaar TC. Crews KR, et al. Among authors: somogyi aa. Clin Pharmacol Ther. 2021 Oct;110(4):888-896. doi: 10.1002/cpt.2149. Epub 2021 Feb 9. Clin Pharmacol Ther. 2021. PMID: 33387367 Free PMC article.

2

The influence of pharmacogenetics on opioid analgesia: studies with codeine and oxycodone in the Sprague-Dawley/Dark Agouti rat model.

Cleary J, Mikus G, Somogyi A, Bochner F. Cleary J, et al. J Pharmacol Exp Ther. 1994 Dec;271(3):1528-34. J Pharmacol Exp Ther. 1994. PMID: 7996467

3

The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans.

Capon DA, Bochner F, Kerry N, Mikus G, Danz C, Somogyi AA. Capon DA, et al. Among authors: somogyi aa. Clin Pharmacol Ther. 1996 Sep;60(3):295-307. doi: 10.1016/S0009-9236(96)90056-9. Clin Pharmacol Ther. 1996. PMID: 8841152 Clinical Trial.

4

Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.

Dyer KR, Foster DJ, White JM, Somogyi AA, Menelaou A, Bochner F. Dyer KR, et al. Among authors: somogyi aa. Clin Pharmacol Ther. 1999 Jun;65(6):685-94. doi: 10.1016/S0009-9236(99)90090-5. Clin Pharmacol Ther. 1999. PMID: 10391674

5

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes.

Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA. Hutchinson MR, et al. Among authors: somogyi aa. Br J Clin Pharmacol. 2004 Mar;57(3):287-97. doi: 10.1046/j.1365-2125.2003.02002.x. Br J Clin Pharmacol. 2004. PMID: 14998425 Free PMC article.

6

A new simple diagnostic assay for the identification of the major CYP2D6 genotypes by DNA sequencing analysis.

James HM, Coller JK, Gillis D, Bahnisch J, Sallustio BC, Somogyi AA. James HM, et al. Among authors: somogyi aa. Int J Clin Pharmacol Ther. 2004 Dec;42(12):719-23. doi: 10.5414/cpp42719. Int J Clin Pharmacol Ther. 2004. PMID: 15624288

7

ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals.

Coller JK, Barratt DT, Dahlen K, Loennechen MH, Somogyi AA. Coller JK, et al. Among authors: somogyi aa. Clin Pharmacol Ther. 2006 Dec;80(6):682-90. doi: 10.1016/j.clpt.2006.09.011. Clin Pharmacol Ther. 2006. PMID: 17178268

8

Pharmacogenetics of opioids.

Somogyi AA, Barratt DT, Coller JK. Somogyi AA, et al. Clin Pharmacol Ther. 2007 Mar;81(3):429-44. doi: 10.1038/sj.clpt.6100095. Clin Pharmacol Ther. 2007. PMID: 17339873 Review.

9

Lack of influence of CYP2D6 genotype on the clearance of (R)-, (S)- and racemic-methadone.

Coller JK, Joergensen C, Foster DJ, James H, Gillis D, Christrup L, Somogyi AA. Coller JK, et al. Among authors: somogyi aa. Int J Clin Pharmacol Ther. 2007 Jul;45(7):410-7. doi: 10.5414/cpp45410. Int J Clin Pharmacol Ther. 2007. PMID: 17725248

10

Role of active metabolites in the use of opioids.

Coller JK, Christrup LL, Somogyi AA. Coller JK, et al. Among authors: somogyi aa. Eur J Clin Pharmacol. 2009 Feb;65(2):121-39. doi: 10.1007/s00228-008-0570-y. Epub 2008 Oct 29. Eur J Clin Pharmacol. 2009. PMID: 18958460 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

319 results

Search Page

Filters